Tuesday, April 03, 2012 1:33:33 AM
Hi Everyone,
SNPK closed up at 0.85$ today which was great for our members and momentum of the stock. Volume is still very strong, and the short positions are as big as ever which could contribute to the current uptrend.
SNPK announced after the bell that they have reached a strategic agreement with Acosta sales and marketing. Acosta has system wide sales of around $50 billion and current customers include corporate giants such as Procter & Gamble and Campbell's both of which owe a large part of their success to amazing advertizing campaigns. In short, SNPK is in very good hands!
SNPK has been associating itself with huge partners such as Acosta and Steve Procko Productions (the studio ads for Pfizer, AT&T and now, Clotamin). Doesn't that have success written all over it?
We have seen reports from happy investors spotting the Clotamin ads on TV (which began airing early on Monday). With 99% of American homes owning at least one TV, Television remains the strongest tool in advertising today, and if the ads influence people as positively as we think they will; Clotamin sales could go through the roof.
Let's not forget that SNPK reached an agreement with NBA legend Paul Silas. By looking at the way things have been going we wouldn't be surprised to see Paul Silas appear in a future Clotamin ad! Those of you who understand the marketing universe, clearly know how effective such an endorsement campaign can be.
Clotamin is a phenomenal product that could contribute to the well being of over 4 million Americans on prescription blood thinners, who will very shortly be aware of its existence and availability due to a strong marketing campaign. Doesn't that seem like something you want to be a part of?
We stand firmly behind our pick, and we think it could become the best 2012 pick for you, our members!
Those of you who did buy SNPK early on must be ecstatic right now, for the rest of you; now may be the best time to look into it!
What would you do if SNPK went to $5+?
Recent PHRX News
- Specialty Pharma Company Moving Higher After Signing LOI for Pharmaceutical-Grade Cocaine • AllPennyStocks.com • 05/23/2024 04:34:00 PM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products • CBDL • Oct 10, 2024 8:00 AM
Foremost Lithium Announces Option Agreement with Denison on 10 Uranium Projects Spanning over 330,000 Acres in the Athabasca Basin, Saskatchewan • FAT • Oct 10, 2024 5:51 AM
Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • ELEM • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM